Clinical trial NCT06638073: Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC
Official title: Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Surgical Procedure, Unspecified
Intensive Care Units (ICUs)
Lead sponsor: Medtronic - MITG
Sponsor class: INDUSTRY
Collaborators: name: Excelar
name: Cloud DX Inc.
name: Bridge Health Solutions
name: Providence Healthcare
First posted: 2024-10-15
Enrollment: 50
Sex: ALL
Minimum age (years): 19
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Patients that have undergone a non-cardiac surgery requiring an inpatient hospital stay and peri-op patients who are in the Surgical High Acuity Unit (SHAU) at SPH.

Brief summary: To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - in hospital and at-home, in patients undergoing non-cardiac surgery.


Eligibility criteria: Inclusion Criteria:

* 19 years or older
* Patients that have undergone a non-cardiac surgery at SPH requiring an inpatient hospital stay
* Peri-op patients who are in the Surgical High Acuity Unit (SHAU) and those followed by Anesthesia Perioperative Outreach team on the ward
* Living within British Columbia, Canada and in an area that is covered by Bell cellular network

Exclusion Criteria:

* Patient refusal
* Lack of capacity to consent to the study (including having received sedative or general anesthetic within the past 24 hours)
* Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
* Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
* No access to cell phone nor landline at home to receive follow-ups
* Preoperatively known to be discharged to a nursing home or rehabilitation facility
* Known allergic reactions to any part material of study devices

Primary outcomes:
measure: Collect patient and clinicians' feedback about the CCPC Platform
timeFrame: From enrollment to the end of follow up at 10 days
measure: Confirm the technical goals of the CCPC platform are met.
timeFrame: From enrollment to the end of follow up at 10 days
measure: Collect patient and clinicians' feedback about the CCPC Platform
timeFrame: From enrollment to the end of follow up at 10 days
measure: Collect patient and clinicians' feedback about the CCPC Platform
timeFrame: From enrollment to the end of follow up at 10 days
measure: Confirm the technical goals of the CCPC platform are met.
timeFrame: From enrollment to the end of follow up at 10 days
measure: Confirm the technical goals of the CCPC platform are met.
timeFrame: From enrollment to the end of follow up at 10 days
Secondary outcomes:
Other outcomes:
Locations:
city: Vancouver
country: Canada
facility: Saint Pauls Hospital
state: British Columbia
Study officials:
References: